rs121434464
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The ENST00000000000(TRNL2):c.32T>C(p.Leu11Pro) variant causes a missense change. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
ENST00000000000 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRNL2 | unassigned_transcript_4814 | c.32T>C | p.Leu11Pro | missense_variant | Exon 1 of 1 | |||
| ND5 | unassigned_transcript_4815 | c.-40T>C | upstream_gene_variant | |||||
| ND4 | unassigned_transcript_4811 | c.*160T>C | downstream_gene_variant |
Ensembl
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Cardiomyopathy, mitochondrial Pathogenic:1
- -
MELAS syndrome Benign:1
The NC_012920.1:m.12297T>C variant in MT-TL2 gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS2 -
not provided Other:1
Variant interpretted as Uncertain significance and reported on 04/12/2017 by GTR ID MNG Laboratories. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source: